Abstract:BackgroundFocal adhesion plays an essential role in tumour invasiveness and metastasis. Hippo component YAP has been widely reported to be involved in many aspects of tumour biology. However, its role in focal adhesion regulation in breast cancer remains unexplored.MethodsTissue microarray was used to evaluate YAP expression in clinical breast cancer specimens by immunohistochemical staining. Cell migration and invasion abilities were measured by Transwell assay. A cell adhesion assay was used to measure the ability of cell adhesion to gelatin. The focal adhesion was visualized through immunofluorescence. Phosphorylated FAK and other proteins were detected by Western blot analysis. Gene expression profiling was used to screen differently expressed genes, and gene ontology enrichment was performed using DAVID software. The gene mRNA levels were measured by quantitative real-time PCR. The activity of the THBS1-promoter was evaluated by dual luciferase assay. Chromatin immunoprecipitation (ChIP) was used to verify whether YAP could bind to the THBS1-promoter region. The prediction of potential protein-interaction was performed with the String program. The ChIP sequence data of TEAD was obtained from the ENCODE database and analysed via the ChIP-seek tool. The gene expression dataset (GSE30480) of purified tumour cells from primary breast tumour tissues and metastatic lymph nodes was used in the gene set enrichment analysis. Prognostic analysis of the TCGA dataset was performed by the SurvExpress program. Gene expression correlation of the TCGA dataset was analysed via R2: Genomics Analysis and Visualization Platform.ResultsOur study provides evidence that YAP acts as a promoter of focal adhesion and tumour invasiveness via regulating FAK phosphorylation in breast cancer. Further experiments reveal that YAP could induce FAK phosphorylation through a TEAD-dependent manner. Using gene expression profiling and bioinformatics analysis, we identify the FAK upstream gene, thrombospondin 1, as a direct transcriptional target of YAP-TEAD. Silencing THBS1 could reverse the YAP-induced FAK activation and focal adhesion.ConclusionOur results unveil a new signal axis, YAP/THBS1/FAK, in the modulation of cell adhesion and invasiveness, and provides new insights into the crosstalk between Hippo signalling and focal adhesion.

YAP induces FAK phosphorylation to inhibit gastric cancer cell proliferation via upregulation of HMGB1

Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells

Mechanotransduction And Cytoskeleton Remodeling Shaping Yap1 In Gastric Tumorigenesis

Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer

YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Helicobacter Pylori‐induced YAP1 Nuclear Translocation Promotes Gastric Carcinogenesis by Enhancing IL‐1β Expression

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

YAP1-CPNE3 positive feedback pathway promotes gastric cancer cell progression

AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis

YAP Signaling in Gastric Cancer-Derived Mesenchymal Stem Cells is Critical for Its Promoting Role in Cancer Progression.

Up‐regulated Acylglycerol Kinase (AGK) Expression Associates with Gastric Cancer Progression Through the Formation of a Novel YAP1‐AGK–positive Loop

Yes-associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis.

VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway

The Hippo/YAP1 Pathway Interacts with FGFR1 Signaling to Maintain Stemness in Lung Cancer.

Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells

EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance

YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients

Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways